Nexalis Therapeutics Limited (ASX:NX1)
Australia · Delayed Price · Currency is AUD 0.0090
-0.0010 (-10.00%)
At close: Sep 18, 2026
Nexalis Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2.06 | -1.62 | -1.21 | -1.44 | -1.93 | -1.11 |
Depreciation & Amortization | 0 | - | - | - | 0.01 | 0 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0.01 | - |
Asset Writedown & Restructuring Costs | - | - | - | 0.01 | - | - |
Stock-Based Compensation | 0.26 | 0.26 | 0.2 | 0.06 | 0.03 | - |
Other Operating Activities | 0.6 | 0.04 | -0.12 | 0 | - | 0 |
Change in Accounts Receivable | -0.47 | -0.47 | 0.36 | -0.77 | -0.01 | 0.06 |
Change in Inventory | - | - | - | - | 0.02 | -0.02 |
Change in Accounts Payable | 0.89 | 0.89 | 0.39 | 0.15 | 0.08 | -0.06 |
Change in Unearned Revenue | - | - | - | - | -0.02 | -0.06 |
Change in Other Net Operating Assets | 0.01 | 0.01 | 0.01 | 0.03 | -0.01 | 0.04 |
Operating Cash Flow | -0.77 | -0.89 | -0.37 | -1.96 | -1.85 | -1.15 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.01 | - | - | - | - | -0.01 |
Sale (Purchase) of Intangibles | - | - | - | - | -0 | -0.01 |
Investing Cash Flow | -0.01 | - | - | - | -0 | -0.03 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | 0.55 | - | - |
Long-Term Debt Issued | - | 1.02 | 0.4 | - | - | - |
Total Debt Issued | 1.06 | 1.02 | 0.4 | 0.55 | - | - |
Long-Term Debt Repaid | - | -0.37 | -0.55 | - | - | - |
Net Debt Issued (Repaid) | 0.32 | 0.65 | -0.15 | 0.55 | - | - |
Issuance of Common Stock | 0.86 | 0.54 | - | - | 1.2 | 2.27 |
Other Financing Activities | -0.08 | -0.06 | -0.01 | -0 | -0.02 | -0.01 |
Financing Cash Flow | 1.09 | 1.13 | -0.15 | 0.54 | 1.18 | 2.26 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 |
Net Cash Flow | 0.31 | 0.24 | -0.52 | -1.42 | -0.67 | 1.08 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.78 | -0.89 | -0.37 | -1.96 | -1.85 | -1.16 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -73.68% | -90.04% | -91.78% | -162.94% | -7444.75% | -638.32% |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -0.12 | -0.33 | 0.08 | -1.59 | -1.08 | -0.97 |
Unlevered Free Cash Flow | 0.01 | -0.25 | 0.14 | -1.59 | -1.08 | -0.97 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.05 | 0.01 | 0.04 | 0.01 | - | - |
Change in Working Capital | 0.43 | 0.43 | 0.76 | -0.59 | 0.05 | -0.04 |